Nutrition and dementia

European Journal of Neurology

Volumn 16, Issue SUPPL. 1, 2009, Pages

  Scheltens, P ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CYANOCOBALAMIN; FOLIC ACID; OMEGA 3 FATTY ACID;

AGNOSIA; ALZHEIMER DISEASE; AMNESIA; APHASIA; APRAXIA; ATHEROSCLEROSIS; BEHAVIOR DISORDER; BRAIN CORTEX; BRAIN SIZE; CAREGIVER BURDEN; CHOLINERGIC ACTIVITY; COGNITION; DEMENTIA; DEPRESSION; DIET SUPPLEMENTATION; DISABILITY; EDITORIAL; ENVIRONMENTAL FACTOR; FAMILY STRESS; GENETIC RISK; HALLUCINATION; HEALTH CARE COST; HEALTH CARE PERSONNEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MALNUTRITION; MENTAL DISEASE; MORTALITY; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NUTRITION; NUTRITIONAL REQUIREMENT; OBESITY; PERSONALITY DISORDER; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

ACETYLCHOLINE; ALZHEIMER DISEASE; AVITAMINOSIS; BRAIN; BRAIN CHEMISTRY; DIETARY SUPPLEMENTS; EUROPE; GENETIC PREDISPOSITION TO DISEASE; HEALTH CARE COSTS; HUMANS; MALNUTRITION; RISK FACTORS;

EID: 69149092352     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2009.02734.x     Document Type: Editorial

References (27)

1. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 2007 3 : 186 191.
2. Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005 366 : 2112 2117.
3. Andlin-Sobocki P, Jonsson B, Wittchen HU, Olesen J. Cost of disorders of the brain in Europe. Eur J Neurol 2005 12 (Suppl. 1) 1 27.
4. Jonsson L, Berr C. Cost of dementia in Europe. Eur J Neurol 2005 12 (Suppl. 1) 50 53.
5. Wimo A, Winblad B, Jonsson L. An estimate of the total worldwide societal costs of dementia in 2005. Alzheimers Dement 2007 3 : 81 91.
6. Mayeux R. Epidemiology of neurodegeneration. Annu Rev Neurosci 2003 26 : 81 104.
7. Raber J, Huang Y, Ashford JW. ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging 2004 25 : 641 650.
8. Heyman A, Fillenbaum GG, Mirra SS. Consortium to Establish a Registry for Alzheimer's Disease (CERAD): clinical, neuropsychological, and neuropathological components. Aging (Milano) 1990 2 : 415 424.
9. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991 41 : 479 486.
10. Cummings JL, Vinters HV, Cole GM, Khachaturian ZS. Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology 1998 51 : S2 S17 discussion S65 S17.
11. Kaduszkiewicz H, Zimmermann T, Beck-Bornholdt HP, van den Bussche H. Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials. Br Med J 2005 331 : 321 327.
12. Burgener SC, Buettner L, Coen Buckwalter K, et al. Evidence supporting nutritional interventions for persons in early stage Alzheimer's disease (AD). J Nutr Health Aging 2008 12 : 18 21.
13. Zandi PP, Anthony JC, Khachaturian AS, et al. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache county study. Arch Neurol 2004 61 : 82 88.
14. Morris MC, Evans DA, Tangney CC, et al. Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change. Am J Clin Nutr 2005 81 : 508 514.
15. Engelhart MJ, Geerlings MI, Ruitenberg A, et al. Dietary intake of antioxidants and risk of Alzheimer disease. J Am Med 2002 287 : 3223 3229.
16. Morris MC, Evans DA, Bienias JL, et al. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. J Am Med 2002 287 : 3230 3237.
17. van Gelder BM, Buijsse B, Tijhuis M, et al. Coffee consumption is inversely associated with cognitive decline in elderly European men: the FINE study. Eur J Clin Nutr 2007 61 : 226 232.
18. Tully AM, Roche HM, Doyle R, et al. Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study. Br J Nutr 2003 89 : 483 489.
19. Barberger-Gateau P, Letenneur L, Deschamps V, Peres K, Dartigues JF, Renaud S. Fish, meat, and risk of dementia: cohort study. Br Med J 2002 325 : 932 933.
20. Corrada MM, Kawas CH, Hallfrisch J, Muller D, Brookmeyer R. Reduced risk of Alzheimer's disease with high folate intake: the Baltimore longitudinal study of aging. Alzheimers Dement 2005 1 : 11 18.
21. Charlton KE, Rabinowitz TL, Geffen LN, Dhansay MA. Lowered plasma vitamin C, but not vitamin E, concentrations in dementia patients. J Nutr Health Aging 2004 8 : 99 107.
22. Helmer C, Peuchant E, Letenneur L, et al. Association between antioxidant nutritional indicators and the incidence of dementia: results from the PAQUID prospective cohort study. Eur J Clin Nutr 2003 57 : 1555 1561.
23. Aisen PS, Egelko S, Andrews H, et al. A pilot study of vitamins to lower plasma homocysteine levels in Alzheimer disease. Am J Geriatr Psychiatry 2003 11 : 246 249.
24. Clarke R, Harrison G, Richards S. Effect of vitamins and aspirin on markers of platelet activation, oxidative stress and homocysteine in people at high risk of dementia. J Intern Med 2003 254 : 67 75.
25. Sommer BR, Hoff AL, Costa M. Folic acid supplementation in dementia: a preliminary report. J Geriatr Psychiatry Neurol 2003 16 : 156 159.
26. Malouf M, Grimley EJ, Areosa SA. Folic acid with or without vitamin B12 for cognition and dementia. Cochrane Database Syst Rev 2003 : CD004514.
27. Malouf R, Areosa Sastre A. Vitamin B12 for cognition. Cochrane Database Syst Rev 2003 : CD004326.